Risorse esterne
Opinione della community
Prezzo Variazione Volume
0.456 -2.98 €
P/E Obiettivo ad 1anno
0 2.53 €

Compra - Vendi

Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Altri utenti che hanno investito

Transations in last week
Buy: 14
Sell : 4

Simone Bonzanini Sebastiano Salemi Cerbero



Arch Therapeutics Inc (ARTH) Stock Rating Upgraded by ValuEngine - Sports Perspectives

Arch Therapeutics (ARTH) traded up 9.495% on Friday, reaching $0.542. 774,143 shares of the company's stock traded hands. Arch Therapeutics has a 52 week low of $0.40 and a 52 week high of $0.95. The stock's market capitalization is $79.68 million. Leggi

Arch Therapeutics Inc (OTCMKTS:ARTH) Awaits FDA Decision - StockNewsUnion

Ironically, Arch Therapeutics Inc (OTCMKTS:ARTH) was trading below $0.50 a year ago before the biotech stock went north and hit a 52-week high of $0.78. Still, the medical device company is trading around double what it was trading at in early 2016. Leggi

Arch Therapeutics Inc (ARTH) Downgraded by ValuEngine to Sell - Transcript Daily

Arch Therapeutics (NASDAQ:ARTH) traded up 1.6211% during midday trading on Wednesday, reaching $0.4827. The company's stock had a trading volume of 63,851 shares. The firm's market cap is $70.97 million. Arch Therapeutics has a 52-week low of ... Leggi

Is Buying ARCH THERAPEUTICS INCORPORATED (ARTH) Here Winning Strategy? - Weekly Register

The stock price of ARCH THERAPEUTICS INCORPORATED (OTCMKTS:ARTH) recorded $-0.005 in recent trading, touching $0.605 and getting interest from avid investors. It's the latest price, but let's analyze how the stock has been doing recently. In the past ...altro » Leggi

Roth Capital Reiterates $3.00 Price Target for Arch Therapeutics Inc (ARTH) - Markets Daily

Shares of Arch Therapeutics (ARTH) traded up 4.167% during mid-day trading on Thursday, reaching $0.475. The company had a trading volume of 257,252 shares. The firm's 50 day moving average is $0.49 and its 200-day moving average is $0.58.altro » Leggi

Arch Therapeutics Inc (OTCMKTS:ARTH) Is 60% Cheaper Than It Should Be - Insider Financial

As generally happens when we see delays in the development of an asset, sentiment weakens further as the delay extends, and the company slowly trades to the downside. In certain situations, this phenomenon can be an opportunity. The question to ask is ... Leggi

HC Wainwright Analysts Give Arch Therapeutics Inc (ARTH) a $3.00 Price Target - Markets Daily

Shares of Arch Therapeutics (NASDAQ ARTH) traded down 2.766% during midday trading on Monday, hitting $0.457. 383,870 shares of the stock were exchanged. The stock's market cap is $67.19 million. The stock's 50-day moving average price is $0.49 ...altro » Leggi

Arch Therapeutics Inc (ARTH) Raised to Hold at Zacks Investment Research - Stock Observer

Shares of Arch Therapeutics (ARTH) traded down 4.95% during midday trading on Thursday, reaching $0.48. 350,688 shares of the company's stock traded hands. The company has a 50-day moving average of $0.49 and a 200-day moving average of $0.59. Leggi

Arch Therapeutics Inc (OTCMKTS:ARTH) A Biotech In Need Of Support - The Oracle Dispatch

For much of 2017, though, shares have traded sideways. Shares started the year at $0.58, rose to $0.78 near the end of January, and have been trending downwards ever since. Arch Therapeutics Inc (OTCMKTS:ARTH) recently released its latest quarterly ... Leggi

Arch Therapeutics Inc (ARTH): HC Wainwright Keeps Buy Rating Today, Has a Target of $3.0000/Share - Weekly Register

Arch Therapeutics, Inc. is a development-stage company. The company has market cap of $74.48 million. The Firm operates as a biotechnology company. It currently has negative earnings. The Firm focuses on developing products to stop bleeding and ...altro » Leggi